Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invicta DiagnosticNSE:INVICTA +3.88%22 OCF Yield % is 3.19 as of Aug. 20, 2026, which is 30% below its 10-year median of 4.57. GuruFocus rates NSE:INVICTA with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 212 Medical Diagnostics & Research companies, Invicta Diagnostic ranks better than 58.02% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Invicta Diagnostic's OCF Yield % or its related term are showing as below:
NSE:INVICTA'
s OCF Yield % Range Over the Past 10 Years
Min: 2.93 Med: 4.57 Max: 8.41
Current: 3.19
During the past 3 years, the highest OCF Yield % of Invicta Diagnostic was 8.41%. The lowest was 2.93%. And the median was 4.57%.
NSE:INVICTA's OCF Yield % is ranked better than 58.02% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.38
vs NSE:INVICTA: 3.19
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Invicta Diagnostic OCF Yield % Related Terms
Invicta Diagnostic OCF Yield % Historical Data
* Premium members only.
The historical data trend for Invicta Diagnostic's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invicta Diagnostic OCF Yield % Chart
Invicta Diagnostic Annual Data
Trend
Mar24
Mar25
Mar26
OCF Yield %
0.00
0.00
3.70
Invicta Diagnostic Semi-Annual Data
Mar24
Mar25
Sep25
Mar26
OCF Yield %
0.00
0.00
0.00
-5.27
NSE:INVICTA vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Invicta Diagnostic's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invicta Diagnostic OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invicta Diagnostic's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Invicta Diagnostic's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invicta Diagnostic (NSE:INVICTA) has a OCF Yield % of 3.19 as of Aug. 20, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Invicta Diagnostic and its competitors. This is 30% below median its historical median of 4.57. Over the past decade, Invicta Diagnostic's OCF Yield % has ranged from 2.93 to 8.41. According to the industry distribution chart, Invicta Diagnostic ranks #89 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 42%.
Is Invicta Diagnostic's OCF Yield % too high?
Invicta Diagnostic's current OCF Yield % of 3.19 is 30% below median its 10-year median of 4.57. Over the past 10 years, this metric has ranged from a low of 2.93 to a high of 8.41. The Medical Diagnostics & Research industry median OCF Yield % is 1.38. Invicta Diagnostic's value of 3.19 is 131.2% above this industry median. Based on the distribution chart, Invicta Diagnostic ranks #89 out of 212 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Invicta Diagnostic has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Invicta Diagnostic's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Invicta Diagnostic ranks #89 out of 212 companies for OCF Yield %. This puts Invicta Diagnostic in the upper half of its industry. The industry median OCF Yield % is 1.38. Invicta Diagnostic's value of 3.19 is 131.2% above this benchmark. Historically, Invicta Diagnostic's own OCF Yield % has ranged from 2.93 to 8.41 over the past decade. While the company's 10-year median is 4.57 vs. the industry median of 1.38, Invicta Diagnostic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.38, based on 212 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Invicta Diagnostic's current OCF Yield % of 3.19 is 131.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Invicta Diagnostic and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invicta Diagnostic's current OCF Yield % is 3.19, which is 30% below median its own 10-year median of 4.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invicta Diagnostic stock overvalued right now?
Invicta Diagnostic (NSE:INVICTA) has a current OCF Yield % of 3.19. The current OCF Yield % is 3.19, which is 30% below median its 10-year median of 4.57 and 131.2% above the Medical Diagnostics & Research industry median of 1.38. Invicta Diagnostic's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Invicta Diagnostic (NSE:INVICTA), the current OCF Yield % is 3.19 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invicta Diagnostic Ltd is engaged in the business of medical and diagnostic services and operates diagnostic centres providing medical testing and allied healthcare services in the Mumbai Metropolitan Region. The Company runs a diagnostic chain comprising seven diagnostic centres and one centralised laboratory across MMR in Maharashtra and operates under a hub and spoke model with a flagship hub in Thane, additional hub centres, spoke centres, and a centralised laboratory. Its service offerings include radiology and imaging, pathology and clinical laboratory tests, teleradiology, and services such as ultrasound, X Ray, CT scan, MRI scan, PET scan, and cardiac diagnostics, with patient convenience supported through home sample collection, house calls, and multiple report delivery options.
22GF Score
Get the complete analysis for NSE:INVICTA
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INVICTA has been successfully added to your 
